Seers (458870) Fundamentals 2026 — P/E 33.6x, Revenue Analysis | SniperIQ
Seers (458870) is a KR-listed Healthcare company in Medical - Specialties with a market capitalization of ₩339.5B, trading at ₩27000.00 on the KOE. This SniperIQ fundamentals page covers Seers's valuation (P/E 33.6x, P/B 19.0x), profitability (net margin 39.8%), revenue (₩48.2B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Seers's market cap?
Seers (458870) has a market capitalization of approximately ₩339.5B, trading at ₩27000.00 on the KOE. Market cap moves with the live share price.
What is Seers's P/E ratio?
Seers's trailing twelve-month P/E ratio is 33.6x, with a price-to-book (P/B) of 19.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Seers?
Seers runs a net profit margin of 39.8%, a gross margin of 68.7%, and an operating margin of 40.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Seers generate?
Seers reported revenue of ₩48.2B for fiscal year 2025, with net income of ₩16.1B and earnings per share (EPS) of 425.92. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Seers pay a dividend?
Seers does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Seers financially healthy?
Seers carries a debt-to-equity ratio of 0.07x and a current ratio of 3.79x, with a market beta of -0.21. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Seers a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Seers (458870) the key facts are: market cap ₩339.5B, P/E 33.6x, revenue ₩48.2B, 52-week range 10416.667-64200. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Seers's full fundamentals live
Get Seers's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.